8th September 2021 | Pharma Updates

IPCA Labs leads Top 10 Domestic Drug firms in August

The drug market has reported a growth of 17.7 %  YoY in August compared to 13.7% in July.

Panacea Biotech supplies 1 mn Sputnik V vaccine doses

Panacea Biotech is the first drug company to locally manufacture Sputnik V.

India starts approving banned FDC drugs

India’s drug regulator has approved 31 fixed-dose combination drugs out of more than 300 banned drugs, after an evaluation by its advisory board. 

Centre govt ties up with drug companies to develop multi-strain Covid vaccine

The Indian government is planning to develop a multi-strain Covid vaccine to combat any variant of Coronavirus.

ABB drives play a key role at Biotech’s Covaxin manufacturing unit

ABB has reported that its drives are playing a critical part in the cleanroom infrastructure of Bharat Biotech.

Biocon enters patent case settlement with Celgene

Celgene earlier filed a complaint against Biocon over patent encroachment by a potential generic medicine made by Biocon.

Drug industry projects 12 billion Covid vaccine doses by end of the year

Covid vaccine production could exceed 12 bn doses by the end of the year and, without a major hurdle, could reach 24 bn by June, as per the International Federation of Pharmaceutical Manufacturers & Associations.